Filter
2224
Filtered Results: 2224
Text search:
medicines
financing
Featured
Recommendations
160
New Publications
705
Language
Document type
No document type
1282
Studies & Reports
472
Guidelines
170
Strategic & Response Plan
147
Manuals
94
Fact sheets
22
Situation Updates
15
Training Material
12
Infographics
5
Resource Platforms
4
Brochures
1
Countries / Regions
Global
131
Kenya
96
Sierra Leone
57
Uganda
56
Ethiopia
53
Western and Central Europe
50
India
50
Liberia
49
Nigeria
48
Africa
47
Zambia
42
Ghana
41
Malawi
41
Myanmar / Burma
41
Nepal
39
Ukraine
38
Bangladesh
37
Rwanda
36
South Africa
36
Latin America and the Carribbean
33
Tanzania
31
Eastern Europe
29
Asia
21
Namibia
21
South–East Asia Region
18
Zimbabwe
16
Philippines
16
Mozambique
16
East and Southern Africa
16
Cambodia
15
Lesotho
14
Syria
13
Senegal
13
Congo, Democratic Republic of
13
Botswana
13
Indonesia
13
Guinea
12
Haiti
12
West and Central Africa
12
Middle East and North Africa
10
Cameroon
9
Venezuela
8
Eastern Europe and Central Asia
8
Russia
8
Eswatini/ Swaziland
8
Pakistan
8
Benin
7
Burkina Faso
7
Afghanistan
6
Paraguay
6
Moldova
6
Sudan
6
Tajikistan
5
Western Pacific Region
5
North America
5
Yemen
5
Georgia
5
South Sudan
5
Somalia
5
North Macedonia
4
Thailand
4
Laos
4
Jordan
4
Germany
4
Vietnam
4
Gambia
3
Albania
3
Peru
3
Lebanon
3
Brazil
3
Ecuador
3
Turkey
2
China
2
Kazakhstan
2
Chile
2
Iran
2
Kyrgyzstan
2
Qatar
2
Jamaica
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Egypt
2
Palestine
2
Central African Republic
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
Niger
1
Uzbekistan
1
Mongolia
1
Bulgaria
1
Armenia
1
USA
1
Lithuania
1
Saudi Arabia
1
Turkmenistan
1
Japan
1
Belgium
1
Mauritius
1
Bosnia and Herzegovina
1
Papua New Guinea
1
Djibouti
1
Mali
1
Chad
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
960
Public Health
157
Clinical Guidelines
109
Key Resources
98
Women & Child Health
90
Pharmacy & Technologies
14
Capacity Building
9
Annual Report MEDBOX
1
Toolboxes
HIV
183
TB
171
COVID-19
138
Mental Health
107
Health Financing Toolbox
84
Planetary Health
77
AMR
73
Global Health Education
72
Disability
53
Caregiver
52
Pharmacy
47
Conflict
47
Rapid Response
45
NCDs
39
Ebola & Marburg
37
NTDs
35
Refugee
23
Natural Hazards
22
Cholera
8
Polio
8
Social Ethics
4
Malaria
4
Zika
3
Specific Hazards
2
The objective of the evaluation is to understand whether the CHW program has achieved its intended objectives, thus contributing to the overarching objectives defined in the HSSP III of improving the health status of the population by “Ensuring universal accessibility of quality health services fo...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215
Integrated Management of Acute Malnutrition National Guidelines
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui...
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui...
Medicina (Kaunas) 2013;49(7):335-40
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The role of evidence in the journey towards universal health coverage is paramount. Financial risk protection monitoring, the major focus of this report, informs where the WHO African Region stands in reducing the financial hardship people face due to health expenses. This report details the status ...
Insufficient funding is hindering the achievement of malaria elimination targets in Africa, despite the pressing need for increased investment in malaria control. While Western donors attribute their inaction to financial constraints, the global health community has limited knowledge of China’s ex...
Donor financing to low- and middle-income countries for reproductive, maternal, newborn, and child health increased substantially from 2008 to 2013. However, increased spending by donors might not improve outcomes, if funds are delivered in ways that undermine countries’ public financial managemen...
From 2000 to 2010, Rwanda implemented comprehensive health sector reforms to strengthen the public health system, with the aim of reducing maternal and newborn deaths in line with Millennium Development Goal 5, among many other improvements in national health. Based on a systematic review of the lit...
Development assistance for health (DAH) is an important part of financing healthcare in low- and middle-income countries. We estimated the gross disbursement of DAH of the 29 Development Assistance Committee (DAC) member countries of the Organisation for Economic Co-operation and Development (OECD) ...
The 2018 global health financing report presents health spending data for all WHO Member States between 2000 and 2016 based on the SHA 2011 methodology. It shows a transformation trajectory for the global spending on health, with increasing domestic public funding and declining external financing. T...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
African Journal of Laboratory Medicine | Vol 7, No 2 | a796 | 06 December 2018
Department of Behavioural Medicine, Lagos State University College of Medicine Ikeja, Lagos Nigeria
Global Mental Health (2015), 2, e5, page 1 of 12. doi:10.1017/gmh.2015.8;
Received 29 January 2015; Revised 8 April 2015; Accepted 15 April 2015
